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Five high-molecular-weight microtubule-associated proteins (MAPS) were identified in brain tissue in previous work from this laboratory (Bloom et al., 1984) . These proteins were termed MAP 1 A, 1 B, 1 C, 2A, and 28. The MAP l's differed from the MAP 2'5, and showed little evidence of interrelationship on the basis of immunological and biochemical comparison. We report here that MAP IA and MAP 1 B are, in fact, related at the level of subunit composition.
Immunoprecipitation of the individual MAPS showed that both contained low-molecular-weight subunits of M, 30,000 and M, 19,000 (light chains 1 and 3). An additional subunit, light chain 2 (M, 28,000), was primarily found in preparations of MAP 1 A. The light chains co-sedimented with microtubules after chymotryptic digestion of the MAPS. This suggested an association of the light chains with the microtubule binding domains of the MAPS, which are identified here as distinct fragments of M, 80,000 for MAP 1 A and 120,000 for MAP 1 B. A panel of monoclonal anti-MAP 1 A and anti-MAP IB antibodies, including one that reacts with a common phosphorylated epitope, was used to examine the distribution of these proteins in the developing rat brain and spinal cord. MAP 1B was found to be abundant in the newborn brain and to decrease with development, in contrast to MAP 1A which increased with development. By immunohistochemistry MAP 1B was found to be highly concentrated in developing axonal processes in the cerebellar molecular layer, the corticospinal tract, the mossy fibers in the hippocampus, and the olfactory nerve. Of particular interest, the mossy fiber and olfactory nerve staining persisted in the adult, indicating continued outgrowth of the mossy fibers as well as olfactory nerve axons. MAP IA staining was, in contrast, weak or absent in developing axonal fibers but moderate in mature axons and intense in developing and mature dendritic processes.
Our results indicate that MAP 1 A and MAP IB are structurally related components of the neuronal cytoskeleton with complementary patterns of expression.
The high-molecular-weight MAPS (microtubule-associated proteins) of brain tissue are a diverse group of proteins involved in microtubule assembly regulation, cytoskeletal organization, and organelle transport. Our laboratory has described 5 polypeptide species, which we termed MAP 1 A, MAP 1 B, MAP 1 C, MAP 2A, and MAP 2B (Bloom et al., 1984 (Bloom et al., , 1985a . MAP 2A and MAP 2B appear to be closely related. They have a number of features distinguishing them from the MAP l's (reviewed in Vallee et al., 1986 ) including stability to elevated temperature and phosphorylation by an associated CAMP-dependent protein kinase. The MAP 2 species are found primarily in dendrites, while MAP 1 A and MAP 1 B are present in axons and glial cells as well. MAP 2 has served as a model for understanding the structure of the MAPS. Analysis of proteolytic digestion products revealed that most of the MAP 2 molecule represents a fibrous projection protruding from the microtubule surface. Chymotryptic fragments of AJ, 32,000 and 34,000 were found to contain the relatively small microtubule binding domain of the molecule. Recently, the full sequence of MAP 2 and its binding domain have been determined (Lewis et al., 1988) . The properties of the MAP l's are less well understood. They show complex and variable electrophoretic behavior, including splitting and shifting in relative mobility under different electrophoretic conditions (Bloom et al., 1984; Herrmann et al., 1985; de Mey et al., 1987; . Their relative abundance in purified microtubules depends on brain region (Vallee, 1982) brain age (Binder et al., 1984; Calvert and Anderton, 1985; Kumagai et al., 1985; Riederer and Matus, 1985) and the presence of nucleotides during microtubule purification . The use of monoclonal antibodies produced against the MAP 1 species has led to diverse descriptions of their distribution and properties. Thus, antibodies to components of the MAP 1 electrophoretic complex have been reported to react with stress fibers (Asai et al., 1985) , centrosomes and kinetochores (Bonifacino et al., 1985; de Mey et al., 1987) and nuclear spots (Sato et al., 1984) , as well as with neuronal processes and glial cells (Bloom et al., 1984 (Bloom et al., , 1985a Huber and Matus, 1984; Calvert and Anderton, 1985) . Even in the latter cases, striking differences in the relative distribution of MAP 1 species were seen within the neuron and between cell types, as well as during development of the nervous system. Underlying these disparate results and the diversity in nomenclature that has been employed for these proteins' is the lack of information regarding the molecular relationship between the MAP 1 species.
In addition, some antibodies to the MAP l's clearly recognize phosphorylated epitopes that are shared with other proteins de Mey et al., 1987) and this may have contributed to the diversity in subcellular distribution patterns.
We have recently purified MAP 1C and found that it is a microtubule-activated ATPase, capable of translocating microtubules in an in vitro gliding assay . Based on the direction of force production along microtubules, we have proposed that it is responsible for retrograde axonal transport . Analysis of the protein by scanning transmission electron microscopy revealed that it is indistinguishable in size and structure from the ciliary and flagellar ATPase dynein (Vallee et al., 1988) . It thus represents a cytoplasmic form of this enzyme and is structurally and functionally distinct from any of the other high-molecular-weight MAPS.
Less is known about the function and properties of MAP 1A and MAP 1B. They are observed as elongated fibrous proteins that decorate the microtubule surface (Vallee and Davis, 1983; Hirokawa et al., 1985; Shiomura and Hirokawa, 1987) . In this respect they seem similar to the MAP 2 polypeptides (Voter and Erickson, 1982) . In other respects they differ from the other MAPS. Unlike MAP 2, which is almost exclusively found in dendrites, both MAP 1A and MAP 1B are found throughout the neuronal cell, as well as in glial cells and other cell types outside of the nervous system (Bloom et al., 1984a (Bloom et al., , 1985a . In addition, they have shown no evidence for associated protein kinase or ATPase activities like MAP 2 and MAP 1C. Chromatographic preparations of MAP 1 A and MAP 1 B do contain "light chains" (Vallee and Davis, 1983) . These species are distinct from subunits identified in MAP 2 (Theurkauf and Vallee, 1982) and MAP 1C , but their function is, as yet, unknown.
Existing evidence suggests relatively little primary structural similarity between MAP 1A and MAP 1B. Eleven of 12 monoclonal antibodies raised against these proteins in our laboratory were specific for either MAP 1A or MAP 1B (Bloom et al., 1984 (Bloom et al., , 1985a Vallee and Luca, 1985) . One antibody did cross-react with a phosphorylated epitope present in both proteins . However, no evidence for extensive sequence homology between MAP 1 A and MAP 1 B was obtained by peptide mapping (Bloom et al., 1985a; Herrmann et al., 1985) or by Northern blot analysis using a cDNA probe corresponding to a microtubule-associated protein of the size of MAP 1B (Lewis et al., 1986) .
The present study was undertaken to investigate further the relationship between MAP 1A and MAP 1B. We find that, despite the observed differences between the 2 proteins, they contain common light-chain subunits and, therefore, appear to be related with regard to higher-order structure. We also find that, despite the widespread expression of MAP 1A and MAP 1B throughout the CNS of the adult (Bloom et al., 1984 (Bloom et al., , 1985a , these proteins show a distinct but complementary distribution in axons and dendrites during development.
Materials and Methods
Antibodies. Five anti-MAP 1B and I anti-MAP 1A antibodies were prepared as described previously (Bloom et al., 1984 (Bloom et al., , 1985a Vallee and Luca, 1985) . The antibodies are named MAP lA-1, -2, -3, -4, -5, -6, and -7 and MAP lB-1, -2, -3, -4, and -5, the names referring to the antigen and the order of isolation of the hybridoma clones. All but one of the antibodies are of the IgG 1 subclass. The exception is "MAP 1 B-3," an IgM that was raised against purified MAP 1B but that recognizes a phosphorylated epitope on MAP lB, MAP lA, and the high-and middle-molecular-weight neurofilament polypeptides . Antibody MAP lA-7 reacted with multiple polypeptides on immunoblots and, therefore, was not used for most of the other types of analysis described here. The other anti-MAP 1A and anti-MAP 1B antibodies have been judged to react with distinct epitopes within the respective MAPS based on cultured cell immunofluorescence patterns (Bloom et al., 1985a; Vallee and Luca, 1986; Vallee et al., 1986; and unpublished observations) , differences in species cross-reactivity, and differential reactivity to bacterially expressed fusion proteins (Hammarback et al., 1989) .
Biochemical methods Microtubule preparation and digestion. Microtubules were prepared by reversible assembly from whole calf brain (Vallee, 1986a) or from calf brain white matter using taxol (Vallee, 1986b) . In both cases the microtubules were resuspended to 2 mg/ml in PEM buffer (0.1 M Pipes, pH 6.6, 1 mM EGTA, 1 mM MgSd,) containing taxol (20 PM), and dieested with 0.35 us/ml chvmotrvnsin (Worthinaton Biochemical) at 37% for 5 min. Thereaction was-stopped using-l mM phenylmethyl sulfonyl fluoride (PMSF). Microtubule binding and nonbinding fragments of the MAPS were separated by centrifugation of the microtubules as described previously (Vallee, 1980 (Vallee, , 1986a , and the binding fragments were dissociated from the microtubules with 0.35 M NaCl (Vallee, 1982) .
Immunoprecipitation. Calf or rat brain tissue was homogenized using a Potter-Elvejhem Teflon pestle homogenizer in 1 vol PEM buffer or in 50 mM Pipes, 50 mM HEPES, 2.0 mM EDTA, pH 7.0, in either case containing 0.5 mM DTT, 1 mM PMSF, 10 pg/ml leupeptin, and 10 & ml TAME. This and all subseauent steps were at O-I"C. The homogenate was centrifuged successively at 25,000 x g for 30 min, and at 150,000 x g for 90 min. The supemate (cytosolic extract) was used fresh or after freezing in liquid nitrogen and storage at -80°C. Nonidet P-40 was added to l%, and the primary antibody as ascites fluid or as hybridoma culture supemate was added (5 ~1 and 1 ml, respectively, per ml of cytosolic extract) and incubated for 2 hr. Goat antibody (anti-mouse immunoglobulins) conjugated to Sepharose beads (Hyclone) was added and incubated overnight with gentle agitation. The beads were washed 4-5 times in Tris-buffered saline (50 mM Tris/HCl, pH 7.4, 150 mM NaCl), and extracted with SDS gel electrophoresis sample buffer (Laemmli, 1970 ) lacking 2-mercaptoethanol to avoid extracting the goat antimouse antibody. The beads were removed by centrifugation at 1000 x g, 2-mercaptoethanol was added to 5% (vol/vol), and the sample was boiled for l-5 min.
Electrophoresis and immunoblotting. SDS gel electrophoresis was performed using the method of Laemmli (1970) . Gels were stained with Coomassie Brilliant blue R250, and the individual bands were analyzed quantitatively by densitometry using a Helena Quik-scan Jr gel densitometer (Vallee and Davis, 1983) . Immunoblotting was performed essentially as described previously (Bloom et al., 1984) . The blots were incubated in 0.1% Amido black in 5:5: 1 methanol:water:acetic acid to visualize total protein or in primary mouse monoclonal antibody (ascites fluid at 1:lOOO) overnight. The antibody reaction was visualized by incubation of the blot for 1 hr in alkaline phosphatase-conjugated sheep anti-mouse IgG (Promega Biotech) followed by reaction in nitro blue tetrazolium and bromo-4-chloro-3-indolyl phosphate (Sigma) for l-5 min (Blake et al., 1984) . The reaction was quantified by densitometry of reflected light using an LKB Ultrascan SL Densitometer and corrected for nonlinearity against a standard curve constructed from blots of purified brain microtubules.
Immunocytochemistry
Brain and spinal cord tissues were obtained from neonatal [postnatal (P) days O-20, PO-201 and adult rats. Animals were perfused transcardially with PBS (50 mM sodium phosphate, pH 7.4, 0.9% sodium chloride) followed by paraformaldehyde/lysine/periodate (McLean and Nakane, 1974; Crandall et al., 1986) or, alternatively, paraformaldehyde/picrate (Stefanini et al., 1967; Bloom et al., 1984) . Following dissection, tissues continued to be incubated in fixative for at least 2 hr. Sections (30-50 brn) were cut with a vibrating microtome (Vibratome, Lancer Instruments) and collected in 0.1 M sodium phosphate buffer, pH 7.4 (PB). Alternatively, sections (20 pm) were cut with a freezing sledge microtome (American Optical). They were then processed freefloating in a series of solutions for indirect immunofluorescence as fol- lows: (1) 10% normal sheep serum in PB containing 0.02% Triton X-100 (TX), overnight at 4°C; (2) mouse monoclonal culture medium containing 0.02% TX, 24-48 hr at 4°C; (3) PB containing TX, 4-5 1 hr rinses; (4) sheep-anti-mouse IgG (Cappel Laboratories) conjugated with rhodamine in this laboratory (Bloom et al., 1984) , diluted 1:20 in PB containing 5-10% normal sheep serum and 0.02% TX, overnight at 4°C; (5) PB, 4-5 1 hr rinses. Sections were mounted from PB onto chrom alum-subbed slides and coverslipped with polyvinyl alcohol or DPX. Alternatively, following incubation in the primary antibody, sections were processed by the avidin-biotin method using fluorescein-conjugated avidin (Vector Laboratories) in the labeling step. Alternatives in protocol were used as noted with neonatal tissues to ensure optimal results. Each variation was applied systematically to a group of littermates through the entire age series. Immunocytochemical data are shown for antibodies MAP lA-1: MAP lB-3, and MAP lB-4. However, all results were confirmed using other anti-MAP 1A and anti-MAP 1B antibodies (MAP lA-2 and -4; MAP lB-1, -2, and -5).
Results
Subunit composition and proteolytic analysis of MAP 1A and MAP 1B Earlier work from this laboratory (Vallee and Davis, 1983) low-molecular-weight subunits, referred to as light chains 1 and 2 (M, 30,000 and 28,000, respectively). The presence of an additional light chain, since referred to as light chain 3 (Kuznetsov and Gelfand, 1987) , was also noted in these preparations. The chromatographically prepared MAP 1 fraction contained both MAP 1A and MAP lB, and, thus, it was uncertain which of these proteins contained the light chains.
To address this question, MAP 1A and MAP 1B were each immunoprecipitated under nondenaturing conditions from cytosolic extracts of calf and rat brain tissue (Figs. 1,2). We found that light chains co-immunoprecipitated with both MAP 1A and MAP 1 B but not with MAP 2. All 3 light chains were present in the MAP 1 A immunoprecipitates. Only light chain 1, at what appeared to be a higher level, and light chain 3 were present in the MAP 1B immunoprecipitates. No light chain 2 was present in the MAP 1B samples shown in Figures 1 and 2 , though trace levels could be seen in other experiments. The same relative composition of light chains was observed using 4 different antibodies to MAP 1A (antibody MAP lA-1, -2, -3, and -4) and MAP 1B (antibody MAP lB-1, -2, -4, and -5). In addition to the light chains, an M, 70,000 species was seen in MAP lA, MAP-60-TUB-** ' AMID0 BLACK lB-1 BLOT Figure 3 . Chymotryptic digestion of MAPS. Microtubules were prepared from calf brain white matter using tax01 and exposed to chymotrypsin. The fragments were then fractionated by microtubule sedimentation with and without added NaCl to dissociate microtubule binding regions of the MAP molecules. The samples were analyzed by electrophoresis (7.5% polyacrylamide), transferred by electroblotting to nitrocellulose paper, and stained with Amido black (left panel) or reacted with anti-MAP 1B (antibody "MAP lB-1," right panel). 1, Untreated microtubules; 2, total microtubule digest; 3 and 4, supemate and pellet after microtubule sedimentation, respectively; 5 and 6, supemate and pellet after sedimentation in the presence of 0.35 M NaCl, respectively. MAP, high-molecular-weight MAPS; TUB, tubulin; APF, MAP 2 assembly-promoting fragments of M, 32,000 and 34,000; LC, light chains 1 and 2. The positions of it4, 120,000 MAP 1B fragment and IV, 60,000 MAP 1A fragment are indicated at left. A contaminant between the MAP and 120 positions may be seen that is not typically found in these preparations. Microtubule binding fragments are found in lanes 2, 4, and 5. The immunoblot shows a disproportionately high level of intensity of endogenous MAP 1B fragments due to incomplete transfer of the MAP 1B band to the nitrocellulose.
MAP lB, and also in MAP 2 immunoprecipitates, and appears to be the same protein identified earlier in chromatographically purified MAP 2 (Vallee et al., 198 1) .
The total content of light chains 1 and 2 ranged from 2.3 to 3.3 mol/mol ofhigh-molecular-weight MAP band for both MAP 1A and MAP 1B (Table 1) . This was close to the value of 2.4 obtained from examination of a chromatographically purified mixture of MAP 1A and MAP 1B (Vallee and Davis, 1983) . The values obtained here are somewhat higher than in the earlier study, possibly due to minor degradation of the high-molecularweight species during the prolonged incubations used for immunoprecipitation. Light chain 3 was present at l-2 mol/mol of MAP 1A and MAP 1B. The M, 70,000 species was consistently present at substoichiometric levels. Because of its lower abundance and its presence in MAP 2 as well as the MAP l's, we are less certain of its role as a subunit of the native MAP 1A and 1B molecules.
To examine further the interaction of the light chains with Ratios oflow-molecular-weight proteins to high-molecular-weight MAPS were determined by densitometry ofelectrophoretic gels (Vallee and Davis, 1983) . Data represent the average of 8-l 1 samples each for calf brain MAP 1A and MAP lB, and 2 samples each for rat MAP 1A and MAP 1B. The molecular weight of the MAP 1 polypeptides was assumed to be 350 kDa.
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Figure 4. Opposite changes in MAP 1A and MAP 1B concentration with rat brain development. Whole brain tissue was dissolved and boiled for 5 min in electrophoresis sample buffer containing 6% SDS. Equal amounts of protein from a series of ages after birth were subjected to electrophoresis on a 6% polyacrylamide gel, transferred to nitrocellulose, and reacted with either anti-MAP 1A (IA, antibody MAP l A-2) or anti-MAP IB (III, antibody MAP lB-4). The reaction product was quantitated by densitometry.
the MAP 1 species, proteolytic degradation of microtubule proteins was performed. The light chains were resistant to chymotrypsin (Fig. 3 , Amido black lane 2) and continued to cosediment with microtubules following degradation of the highmolecular-weight MAP 1 bands (Fig. 3 , Amido black lane 4). In addition to the light chains, a number of additional microtubule binding polypeptides were seen. These included a pair of fragments (MT 32,000 and 34,000) generated from MAP 2 (Vallee, 1980 ) and a fragment of M, 120,000. This fragment, which we find to be resistant to further proteolysis, was judged to derive from MAP 1B on the basis of immunoblotting with anti-MAP 1 B antibodies (Fig. 3, blot) . Extraction of the microtubules with 0.35 M NaCl, which releases the MAPS, revealed the presence of an additional fragment of M, 60,000 (Fig. 3 , Amido black lane 5). Although none of the monoclonal antibodies recognized this fragment, it appears to derive from MAP 1 A. It is not seen in digests of purified MAP 2 (Vallee, 1980) , nor is it recognized by a monoclonal antibody to the MAP 2 microtubule binding fragments (R. Obar, J. Hyams, J. Dingus, and R. B. Vallee, unpublished observations). It is present at equal levels in digests of microtubules from both gray white matter. This rules out the possibility that it derives from MAP lB, which is almost undetectable in gray matter microtubule preparations (Bloom et al., 1985a) . The fragment can be seen only when separated from tubulin (Fig. 3 , cf. Amido black lane 5 with lane 4) and, thus, it has remained undetected until now. The basis for this unusual electrophoretic behavior is not known.
Developmental expression of MAP 1A and MAP 1B To compare the expression of MAP 1A and MAP 1B during brain development, whole brain tissue was dissolved in SDS sample buffer and examined by quantitative immunoblotting (Fig. 4) . MAP 1 B was found to be most abundant in the newborn rat brain and to decline in amount with age. In contrast, MAP 1A was present at lower concentration in the newborn and increased with age. By immunofluorescence microscopy, we observed intense MAP 1B reactivity in newly forming axonal processes, apparently explaining the high concentration of MAP 1B in early postnatal development. MAP lA, on the other hand, was found to rise in concentration during development in a number of cellular structures. In our analysis, particular emphasis has been placed on regions in which extensive postnatal development of axonal processes is known to occur, to test whether the presence of MAP 1B is generally associated with axonal development. The regions of interest were the cerebellum, where parallel fibers are laid down through at least P20; the olfactory bulb, where olfactory nerve fibers continue to develop after birth and even into adulthood, the corticospinal tract, where the invasion of neocortical efferent fibers into the brain stem and spinal cord can be followed almost entirely after birth, and the hippocampus, where the mossy fibers of the dentate gyrus invade subfields of the hippocampus proper after birth and apparently into adulthood (see below). These data are described region by region below.
Cerebellum MAP IB. The most prominent staining at P5 is of the molecular layer and of the deep external granule layer (Fig. 5) . A decreasing gradient of staining across the molecular layer was apparent by PlO, with the brightest labeling still occurring at the border between the external granule layer and the superficial molecular layer. By P20, intense staining occurred only in the external granule layer. The intense staining in the superficial layers of the cerebellar cortex corresponds to the position of premigratory, postmitotic granule cells whose parallel fiber axons are just beginning to extend from the parent cell body horizontally across the molecular layer. The decreasing intensity of staining with age and at deeper regions of the molecular layer is indicative of a decrease in the concentration of MAP 1B with maturation of the granule cell axons. We also note intense staining of descending granule cell somata and their leading processes even as they descend deeply into the internal granule layer (Fig. 5) .
P5-PlO Purkinje cell dendrites and somata and Bergmann glia appear virtually negative for MAP 1B against the more intensely staining background of the parallel fibers in the molecular laver. Beginning at P20 and by the adult stage, however, moderate staining of the Purkinje cell dendrites and somata can be seen (Figs. 5D, 13 ) as well as moderate staining of the parallel fibers of the granule cells (Bloom et al., 1985a) .
MAP IA. The somata and proximal dendritic segments of Purkinje cells are prominently stained with anti-MAP 1A at P5 and throughout their development (Fig. 6) . The distal dendritic segments are not immunoreactive until P20. The molecular layer itself becomes more prominently and rather uniformly labeled by PlO, showing a homogeneous and dense pattern consistent with the staining of bundles of parallel fibers (Fig. 6) . However, this staining eventually disappears by adulthood (Bloom et al., 1984) . Some weak staining of the deep external granule layer is occasionally seen. However, this does not appear to be associated with a gradient of staining in the molecular layer as we see with MAP 1B.
Olfactory bulb staining persists into adulthood (Figs. 7, 13 ). The staining of olfactory nerve axons never appears to extend appreciably into the terminal regions within the glomeruli. At PO, an additional intense, deeply situated band of labeling can also be seen, corresponding to the mitral body layer (Fig. 7) . Immunoreactivity MAP IB. One of the most intensely stained features of the appears to be localized between, rather than within, mitral cell olfactory bulb at PO is the olfactory nerve layer (Fig. 7) . This somata, probably corresponding to staining of the proximal ax-et al. l MAP 1 Structure and Development Figure 6 . Anti-MAP IA-1 immunoreactivity in the cerebellum at P5 (A), PlO (B), and P20 (C'), as seen in sag&al section. Arrowheads indicate the border between the deep, premigratory zone of the external granule layer and the superficial part of the molecular layer. Abbreviations are as in Figure 5 . Scale bar, 100 pm.
onal segments of these cells (see Hinds and Ruffett, 1973) . Beonward, the somata and dendritic processes of all principal and ginning at P7, the somata and dendrites of olfactory bulb prinintrinsic neurons are prominently labeled, particularly where cipal and intrinsic neurons, including mitral, tufted, and granule these processes converge in the external plexiform and glomercells, among others, become stained with anti-MAP 1B. ular layers (Fig. 8) . The staining of somata and dendrites is MAP IA. The olfactory nerve layer remains unstained comparable to that seen with anti-MAP 1B at P7 and older, throughout development (Fig. S) , in direct contrast to persistent although the anti-MAP 1 A staining is more extensive, involving MAP 1B staining of the olfactory nerve. However, from PO more cellular profiles and processes within the bulb. Corticospinal tract corresponding to the time of arrival of the corticospinal fibers (e.g., Schreyer and Jones, 1982) . By P20 and into adulthood, MAP IB. At PO the corpus callosum is intensely labeled by anti-MAP 1B immunoreactivity is no longer found associated with MAP 1 B, and moderate staining of the spinal cord dorsal funicucorticospinal tract axons in either the medulla or cervical spinal lus is seen (Fig. 9A) . However, by P7-10 ( Fig. 9B ), intense cord (Figs. 9D, 13) . staining of the dorsal funiculus of the cervical spinal cord and MAP IA. There is negligible staining of the corticospinal tract, the corticospinal tract of the medulla (Fig. 9C) is observed, including myelencephalic and spinal components of corticofugal fibers, by anti-MAP IA at PO-7 (Fig. 10) . By Pl 0, there is more moderate labeling of fibers, e.g., in the ventral brain stem, together with cells embedded within the corticospinal tract which may be developing oligodendrocytes.
Hippocampus (CA3 field) pocampus (Fig. 11 ). This expression persists into adulthood (see Fig. 13 ). There is no apparent staining of the somata and dendrites of CA3 pyramidal cells until P20. Beginning at that point and in the adult, the stained mossy fibers and pyramidal cell dendrites are intermingled. MAP IA. At all ages, the somata and dendrites of CA3 py-MAP IB. From P5 onward, there is prominent staining ofmossy ramidal cells are lightly stained (Fig. 12) . There is no apparent fiber axons and terminal fields within the CA3 field of the hipstaining of mossy fiber axons. Distribution of a phospho-MAP 1 epitope and middle-molecular-weight neurofilament polypeptides were also intensely labeled. This made it difficult to determine the One of the antibodies raised against MAP lB, "MAP lB-3," distribution of the phospho-MAP 1 epitope in mature brain. was found to recognize a phosphorylated epitope common to However, because the phosphotylated neurofilament antigens MAP 1B and MAP 1A Figure   IO . Anti-MAP lA-1 immunoreactivity in the cervical spinal cord at PO (A) and P7 (II) and in the ventral medulla at PlO (c) and P20 (0). Conventions for display of the panels and use of symbols are as in Figure 9 . The asterisk marks a tissue artifact. Scale bar: 100 pm for A and C, 250 pm for B and D.
We focused our analysis on the cerebellar cortex, where neu- Fig. 14A ), the pattern of reactivity is indistinguishable from that rofilaments are known to be abundant in basket cell axons and of the other anti-MAP 1B antibodies (Fig. 5) , with intense stainabsent from parallel fibers and Purkinje cell dendrites and soing observed in the external granule cell layer and in the more mata (Sternberger and Sternberger, 1983; Shaw et al., 1986) .
superficial region of the molecular layer. Staining of dendritic Figure 14 shows the immunofluorescence pattern observed processes in the molecular layer characteristic of the anti-MAP with the anti-phospho-MAP 1 antibody in the cerebellum as a IA antibodies is not observed. Thus, it appears that MAP 1B function of developmental stage. Early in development (P5-10; in developing axons contains the MAP lB-3 epitope in the phosphorylated form. On the other hand, MAP 1A in developing dendrites must contain the epitope in an unphosphorylated form, or the epitope must be masked. Prominent staining of the premigratory zone of the external granule layer is still evident by P20, along with light staining of more mature parallel fibers across the molecular layer (Fig. 14B) . This is the pattern characteristic of the other anti-MAP 1B antibodies (Fig. 5) . Because neurofilaments are absent from both mature and immature parallel fibers (Shaw and Weber, 1982; Shaw et al., 1986) , the observed staining by antibody MAP 1 B-3 offers evidence that MAP 1 B is in the phosphorylated form in these processes throughout their development. Purkinje cell dendrites and somata are unstained by antibody MAP lB-3. This is despite the clear presence of both MAP 1A and MAP 1B (Figs. 5, 6 ), suggesting that both proteins are in the unphosphorylated form in these structures. The most striking staining observed at this stage is that of the basket cell axons around the Purkinje cell bodies (Fig. 14) and of large-caliber axons in the white matter. This pattern is characteristic of anti-phospho neurofilament antibodies (Stemberger and Stemberger, 1983; Shaw et al., 1986) .
In the adult, the most prominent staining with anti-MAP lB-3 is of basket cell axons and large-caliber axon bundles in the white matter (Fig. 14C) , a pattern characteristic of antiphospho neurofilament antibodies as noted above. Light staining of some dendrites of Purkinje cells can also be seen in some sections (not shown). These structures are not stained with antiphospho neurofilament antibodies (Shaw et al., 1986) . 
Discussion
We have uncovered further differences between the 2 proteins as well. We identify different microtubule binding fragments Structure of MAP IA and MAP IB generated from the 2 proteins (Fig. 3) . We also note that MAP Earlier work indicated a general lack of cross-reactivity between 1B contains little or no light chain 2 (Figs. 1, 2) . We have MAP 1A and MAP lB, clear differences in their peptide maps, observed this as a consistent feature of MAP 1B immunopreand a significant difference in their apparent affinities for micipitated by several different antibodies, from both gray and crotubules (Bloom et al., 1984 (Bloom et al., , 1985a Vallee and Luca, 1985) .
white matter (unpublished observations), and from 2 different In addition, hybridization with a cDNA probe corresponding animal species (Figs. 1, 2 ; Table 1 ). This observation is entirely to a portion of what may be MAP 1B revealed no evidence for consistent with our earlier finding that the ratio of light chain a related gene (Lewis et al., 1986) . Nonetheless, our biochemical 1:light chain 2 was greater in white matter microtubules than results indicate that MAP 1A and MAP 1B are, in fact, strucin gray matter microtubules (Vallee and Davis, 1983) , in that turally related, as revealed by their pattern of associated lightthe white matter microtubules always contain substantially more chain subunits (Figs. 1, 2) . Work is currently under way in our MAP 1 B than the gray matter microtubules. Why MAP 1A and laboratory to examine the possibility of common light-chain MAP 1B differ in this respect is uncertain, though our finding binding sequences in MAP 1A and MAP 1B using molecular of trace levels of light chain 2 in MAP 1B immunoprecipitates cloning techniques (Hammarback et al., 1989) .
suggests that binding is possible but not favored. Whatever the ONL , Figure 13 . Anti-MAP lB-4 immunoreactivity in the cerebellum (A), main olfactory bulb (B), cervical spinal cord (C), and hippocampus (0) know if this is evidence that light chains 1 and 2 are functionally This should be useful in their identification in mammalian sysinterchangeable, or whether light chain 2 is subject to proteolytic terns, though we note that in preliminary immunoprecipitation degradation in the chicken. experiments with chicken brain using antibodies "MAP 1 A-2,"
Our data suggest that for both MAPS, the light chains are "MAP lA-4," and "MAP lB-2," both MAP 1A and MAP 1B situated at the microtubule binding end of the molecule (Fig.  contained light chains 1 and 3 , with no light chain 2 detectable 15). This conclusion is based on the persistence of the light Figure 14 . Anti-MAP lB-3 immunoreactivity in the cerebellum at P7 (A), P20 (B), and in the adult (C'). Arrowheads in A and B indicate the border between the deep, premigratory zone of the external granule layer and the superficial part of the molecular layer (ML). Abbreviations: PCL, Purkinje cell layer; WM, white matter deep to the cerebellar cortex. Scale bar, 100 pm.
chains in microtubule pellets following chymotryptic digestion (Fig. 3) along with microtubule binding fragments of MAP 1A and MAP 1B. Preliminary evidence has indicated that purified light chains may bind to microtubules directly (R. Obar, unpublished observations), suggesting that these polypeptides could be directly involved in microtubule binding. They could therefore be responsible for differences in binding affinity to microtubules (Bloom et al., 1985a ) and might influence the relative microtubule assembly-promoting activity of the 2 proteins. Accordmg to our model (Fig. 15) , MAP 1A and MAP 1B are structurally different from MAP 2, which has a simpler microtubule binding domain (Vallee, 1980; Lewis et al., 1988) . Our data are consistent with those obtained with a monoclonal antibody to light chain 1 (Kuznetsov et al., 1986; Kuznetsov and Gelfand, 1987 certain. Digestion of the MAPS with chymotrypsin resulted in the production of a fragment of A4, 120,000, the same as our MAP 1 B fragment, and this species also co-immunoprecipitated with light chain 1. Our M, 60,000 MAP 1A fragment was not observed in that study. This is not surprising in view of our observation that it is less stable to further digestion than the M, 120,000 MAP 1B fragment.
D@erential distribution in the CNS
In previous work we found that MAP 1A and MAP 1B were both more widely distributed than MAP 2, which is largely restricted to neuronal dendrites. Some differences in the relative intensity of anti-MAP 1A and anti-MAP 1B staining could be seen in the adult cerebellum, but both proteins could be found throughout the neuron and in non-neuronal cells as well. Because MAP 2 is largely absent in axons, we proposed that MAP 1A and MAP 1B were the major structural components of the axonal cytoskeleton observed by freeze-etch electron microscopy (Hirokawa et al., 1985) .
postnatal development is consistent with the known time course of appearance of mossy fibers during this period (Gaarskjaer, 1985) . The staining of the adult mossy fibers by anti-MAP 1B antibodies reported here supports claims of the continued generation of granule cells in the adult dentate gyrus. The number of granule cells in this region has been reported to increase in the adult due to continued cell division (Bayer, 1982; Crespo et al., 1986) . This would, presumably, result in the generation of new mossy fibers, conceivably at a rate of 1000 a day throughout life, assuming one axon per new granule cell (Bayer, 1982) . However, we are unaware of any studies that have attempted to demonstrate directly that such axonal growth in the adult actually takes place. Our data thus provide the first evidence that such growth does, indeed, occur and indicate that immunocytochemical staining with anti-MAP 1B antibodies offers a means for detecting the newly forming processes.
We find here that the 2 proteins have a more or less complementary distribution during development (Fig. 4) . MAP 1B is much more abundant in the newborn rat brain than in the adult; the reverse is true for MAP 1A. The greater abundance of MAP 1 B in the neonate is associated with the intense labeling of newly forming axonal processes by anti-MAP 1B antibodies during the first weeks of life, which diminishes as the axons mature. The increasing concentration of MAP 1A with development corresponds to the expansion of mature dendritic arbors in which this protein is particularly abundant.
The overall decline in MAP 1B expression with age is associated with a reduction in the intensity of expression in axonal processes generally, with the exception of the olfactory nerve and mossy fiber axons, and the emergence of a moderate level of expression in dendrites and somata throughout the CNS.
In contrast to the distribution observed for MAP 1B in the neonatal CNS, MAP 1A is associated with neuronal somata and only the proximal portions of dendrites (e.g., Fig. 6 ; cf. Cambray-Deakin et al., 1987) . With increasing age, MAP 1 A is found throughout the dendritic arbor and in many axonal processes (Bloom et al., 1984) , although it appears to be only transiently expressed in the parallel fiber axons (Fig. 6; cf. Cambray-Deakin et al., 1987) . The precise schedule of MAP 1 B expression is region-specific.
Thus, while our evidence indicates that MAP 1A and MAP For example, in the cerebellum from PO through P20 these 1B are structurally related proteins, their developmental and antibodies intensely stain the premigratory zone of the external spatial expression differ in many ways (summarized in Fig. 16 ). granule layer and the superficial part of the molecular layer ( Fig. MAP 1 B is most prominently associated with developing axonal 5) where the horizontal outgrowth of the granule cell parallel processes, which may be susceptible to some degree of structural fiber axons takes place (Altman, 1972) . In the olfactory bulb, and synaptic remodeling. In contrast, MAP 1A is most promolfactory nerve axons are prominently stained by MAP 1B aninently associated with the proximal segments of developing tibodies at the earliest age examined (PO). Staining persists dendritic arbors, which we presume have a more stable configthroughout the postnatal period and into adulthood. (Figs. 7, uration than the more distal, growing tips. We suggest that MAP 13), consistent with the continuing postnatal growth of these IA may have a greater stabilizing effect on microtubules than axons (Graziadei and Monti-Graziadei, 1978; Farbman and MAP lB, which would allow for more or less facility in cyto- Squinto, 1985) . In the corticospinal tract, staining is moderate skeletal reorganization. In support of this notion is the obserat PO and then peaks in intensity in the medulla and cervical vation that MAP 1B alone among the several MAPS we have spinal cord at P5-7 (Fig. 9 ) the age of peak axonal growth investigated copurified inefficiently with microtubules (Bloom through these regions (Donatelle, 1977; Schreyer and Jones, et al., 1985a) . This most likely reflects a lower affinity of MAP 1982). Beyond this period of peak growth, MAP 1B immuno-1B than MAP 1A or MAP 2 for microtubules, which should, reactivity in the corticospinal tract is undetectable (Figs. 9, 13 ).
in turn, imply a weaker ability to stabilize microtubules. The staining pattern in the hippocampus with anti-MAP 1B antibodies is of particular interest. Mossy fiber axons in the CA3 region begin to show staining by MAP 1 B antibodies at P5, but this immunoreactivity increases dramatically in intensity through P20 and persists in the adult (Figs. 11, 13) . The staining during drawing depicts a neuronal cell soma with nucleus, 2 dendrites at the top, and a descending axon. For MAP 1 B, intense expression restricted to the axon of a developing neuron gives way to more moderate expression in all compartments of the mature neuron, including the emergence of somatic and dendritic expression not found early in development. In contrast, for MAP lA, moderate expression in the soma and the proximal segments of the dendrites of a developing neuron gives way in the mature neuron to more intense expression in the soma and entire dendritic tree and to the emergence of moderate expression in the axon.
epitope on the heavy-and middle-molecular-weight neurofilament polypeptides, which greatly complicates the analysis of the pattern of immunoreactivity observed in the adult rat. However, because the phosphorylated neurofilament antigens appear late in development (Shaw and Weber, 1982; Shaw et al., 1986) and the distribution of neurofilaments in cerebellar cortex is well documented (Sternberger and Sternberger, 1983; Shaw et al., 1986) , it is possible to interpret the distribution of the phospho-form of MAP 1A and MAP 1 B in the developing cerebellum (Fig. 14) .
We find that our anti-phospho MAP 1 antibody stains newly forming parallel fiber axons in a pattern indistinguishable from that observed with the other anti-MAP 1B antibodies (Figs. 5, 14) . Since MAP 1A and neurofilaments are absent from these structures, we conclude that the pattern of immunoreactivity that we see is that of phospho-MAP 1B. In somata and dendritic processes of the newborn rat cerebellum, where we know MAP 1A to be abundant and the neurofilaments and MAP 1B to be absent, no reactivity with the MAP lB-3 antibody was seen.
Thus, MAP 1A is in the nonphosphorylated form in developing dendrites. This pattern of distribution of the phosphorylated epitope is the same as that reported for phosphorylated neurofilament epitopes in mature brain, which also are expressed in axons but not in dendrites or somata (Shaw et al., 1986) . It is the converse of the distribution of a phosphorylated epitope on the tau MAPS (Papasozomenos and Binder, 1987) .
In the more mature cerebellum (Fig. 14, B, C) , the absence of staining of Purkinje cell somata and the rare light staining of Purkinje cell dendrites by anti-MAP lB-3, despite their prominent staining by other anti-MAP 1 A and 1 B antibodies, further
indicates that these structures contain unphosphorylated forms of these MAP 1 proteins. The prominent staining of basket cell and white matter axons with anti-MAP lB-3, which is characteristic of anti-phospho-neurofilament immunoreactivity and is not seen with other anti-MAP 1 antibodies, is consistent with the documented cross-reactivity of this antibody with phosphorylated high-and middle-molecular-weight neurofilaments .
Comparison with other antibodies The developmental changes in the pattern of immunoreactivity observed with our MAP 1 antibodies show similarities to, as well as differences from, those found with several other MAP antibodies. For example, monoclonal anti-"MAP 1" of Matus and colleagues (Bernhardt et al., 1985) shows an increase in overall staining intensity with age, consistent with its identification as MAP 1A (Matus, 1988) . However, the regional staining pattern observed with this antibody differs from that seen with our anti-MAP 1A antibodies. For example, in the cerebellum, the anti-MAP 1 antibody shows an intense staining of parallel fiber axons in the cerebellar molecular layer that decreases with age, similar to the pattern seen with our anti-MAP 1 B antibodies. The staining of Purkinje cell somata and dendrites seen with the anti-MAP 1 antibody (Bemhardt et al., 1985) is, on the other hand, essentially the pattern observed with our anti-MAP 1 A antibodies. Likewise, monoclonal antibody GlO of Calvert and Anderton (1985; see also Calvert et al., 1987) which reacts with a MAP 1 protein from 2-d-old rat brain named "MAP 1 X," stains only developing axons in the immature and mature brain. This pattern is similar to the intense immunoreactivity we observe in outgrowing axons with our anti-MAP 1 B antibodies. However, it represents only a subset of the anti-MAP 1 B staining pattern. Staining of adult mossy fibers with antibody GlO is weak, and more general staining of adult neurons and glia is not reported. Perhaps the GlO antibody recognizes an epitope of MAP 1B that is expressed only in outgrowing axons but is effectively masked otherwise (Calvert et. al., 1987) .
A monoclonal antibody to a protein identified as "MAP 5" Riederer et al., 1986) reacts with a protein doublet, the heavier of which (320 kDa) is similar in size to MAP 1B. The developmental staining pattern shows many similarities to that of MAP 1B since both are initially expressed in outgrowing axons and ultimately expressed in both axons and dendrites. We note that the immunoreactivity of Purkinje cell dendrites relative to parallel fibers in the molecular layer at P5-10 appears much more intense with the anti-MAP 5 antibody ) than what we have observed with anti-MAP 1B. Moreover, staining of hippocampal mossy fibers with anti-MAP 1 B persists into adulthood, whereas mossy fiber staining with the anti-MAP 5 antibody does not ). However, it is possible that these differences in staining pattern reflect differences in histochemical procedure rather than in epitope distribution.
In view of these differences, it is not clear how MAP 1X and MAP 5 are related to MAP 1A and MAP 1B. It is possible that the antibodies used in the other studies recognized epitopes hidden at some developmental stage, or modified, for example, by phosphorylation. We have clearly found that an antibody directed at one phosphorylated epitope, MAP lB-3, shows a number of differences in its pattern of immunoreactivity from our other anti-MAP 1 antibodies. One additional antibody of this class has now been documented (de Mey et al., 1987) , and others may, indeed, be common. We note, in fact, that the antiphospho neurofilament antibody RT97 (Wood and Anderton, 198 1) was observed to react with developing parallel fibers (Cambray-Deakin and Burgoyne, 1986) despite the absence of neurofilaments in these processes. This antibody appears to us to cross-react with higher-molecular-weight polypeptides in cerebellar homogenates (Cambray-Deakin and Burgoyne, 1986; see their figure 2) which could be MAP 1A and MAP 1B.
Because of these problems and the even greater diversity of results obtained using anti-MAP 1 antibodies outside of the nervous system (see introductory remarks), it will be important to understand these proteins at the molecular level. We have begun this process by showing that MAP 1A and MAP 1B are, in fact, related in higher order structures, and we have provided some structural criteria for their identification in general. This should provide a basis for on-going and future work directed at comparing these proteins at the primary sequence level.
Note added in proof Dr. A. Matus has informed us that our MAP lB-4 antibody recognizes a fusion protein encoded by a MAP 5 cDNA clone, indicating that MAP 5 is equivalent to or closely related to MAP 1B. He also found that anti-MAP 1X reacted with immunoprecipitated MAP 5, suggesting that MAP 1X is also equivalent to MAP 1B.
